Skip to content
Disclosery

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 37 holding rows worth $411,104,315.

Accession
0001958125-25-000004
Filer
CIK 1958125
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 37 entries on the cover page, a total value of $411,104,315 stated on the cover page (in dollars after the unit check, H1), rows summing to $411,104,315 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BECTON DICKINSON & CO075887109COM203,965$46,720,223dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM758,533$33,474,061dollars as filed
BRIDGEBIO PHARMA INC10806X102COM962,883$33,286,865dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock435,588$31,571,418dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR195,523$30,474,215dollars as filed
CYTOKINETICS INC23282W605COM NEW585,812$23,543,784dollars as filed
VERACYTE INC COM92337F107Stock762,225$22,599,971dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,733,701$21,298,517dollars as filed
Eli Lilly and Company532457108COM23,682$19,559,201dollars as filed
Intuitive Surgical,Inc.46120E602COM36,499$18,076,860dollars as filed
LIVANOVA PLCG5509L101SHS381,648$14,991,133dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM763,471$13,849,364dollars as filed
INSPIRE MED SYS INC COM457730109Stock85,877$13,678,489dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY704,864$12,201,196dollars as filed
SOLENO THERAPEUTICS INC834203309COM160,962$11,500,735dollars as filed
UNIQURE NVN90064101SHS830,325$8,801,445dollars as filed
REGENERON PHARMACEUTICALS COM75886F107Stock12,261$7,776,294dollars as filed
SOLENO THERAPEUTICS INC834203909CALL100,000$6,500,000dollars as filedcall
SEPTERNA INC COM81734D104Stock1,024,245$5,930,379dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,088,691$4,637,824dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock611,639$4,544,478dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock114,616$4,478,047dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock389,384$3,967,823dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM611,608$3,963,220dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK355,640$3,467,490dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock295,148$2,331,670dollars as filed
OUTSET MED INC690145206COM NEW166,666$1,843,326dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K958COM100,000$1,250,000dollars as filedput
KYVERNA THERAPEUTICS INC501976104COMMON STOCK586,909$1,132,734dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$719,430dollars as filed
Mersana Therapeutics Inc59045L106Common Stock1,705,036$586,873dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK202,139$582,160dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK155,622$582,026dollars as filed
HYPERFINE INC44916K106Common Stock760,035$544,413dollars as filed
ATAIBECKLEY INCN0731H103Equity196,858$267,727dollars as filed
FRACTYL HEALTH INC35168W103COM214,236$254,941dollars as filed
SENSEI BIOTHERAPEUTICS INC81728A108COM294,374$115,983dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-25-000004this filing2025-05-15acceptance time not in the bulk data set